ChromaVision, USC Test Cancer Product
- Share via
Barbara Marsh covers health care for The Times. She can be reached at (714) 966-7762 and at barbara.marsh@latimes.com
ChromaVision Medical Systems Inc. is pushing ahead with clinical trials, too.
The San Juan Capistrano biomedical company has contracted with several USC doctors to test a product intended to detect minute quantities of cancer cells that have spread away from a patient’s primary tumor to other parts of the body. The company said its product promises to automate the process of assessing the number of dispersed cells in bone marrow.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
